Cargando…
Omalizumab as add-on therapy in patients with asthma and allergic bronchopulmonary aspergillosis
Autores principales: | da Cunha, Fernanda Sales, Valle, Solange Oliveira Rodrigues, Elabras, José, Dortas, Sérgio Duarte, França, Alfeu Tavares |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Pneumologia e Tisiologia
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467590/ https://www.ncbi.nlm.nih.gov/pubmed/30517345 http://dx.doi.org/10.1590/S1806-37562017000000325 |
Ejemplares similares
-
Omalizumab in chronic spontaneous urticaria (CSU): experience in three cases
por: Valle, Solange Oliveira Rodrigues, et al.
Publicado: (2015) -
Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
por: Ashkenazi, Moshe, et al.
Publicado: (2018) -
Allergic bronchopulmonary aspergillosis treated successfully for one year with omalizumab
por: Collins, Jennifer, et al.
Publicado: (2012) -
Steroid sparing effect of omalizumab in seropositive allergic bronchopulmonary aspergillosis
por: Beam, Keith T., et al.
Publicado: (2015) -
Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis [Erratum]
Publicado: (2018)